AstraZeneca quits cancer pipeline efforts — Eisai's weight loss drug is pulled from market due to safety concerns — Melinta seeks buyout bids to escape bankruptcy — See more on our front page news TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREEDismiss Notice
Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.Dismiss Notice
The Politics of Healthcare
This board is for discussions about the effects of politics on the healthcare industry (pharmaceutical, device, etc). The board is moderated and posts will be reviewed before going live. Posts should be related to the subject matter and simple unsupported attacks on other users or others’ views will not be allowed.